Paper32335166
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
Stockdale AJ and 7 others. J Hepatol, 2020. Cited by 565 papers, by iCite.
Cite this record
ConductScience Library. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. Papers, record 32335166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32335166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coinfection | Major topic |
| Hepatitis B | Major topic |
| Hepatitis B virus | Major topic |
| Hepatitis D | Major topic |
| Hepatitis Delta Virus | Major topic |
| Adult | |
| Carcinoma, Hepatocellular | |
| Female | |
| Genotype | |
| Hepatitis Antibodies | |
| Hepatitis B Surface Antigens | |
| Homosexuality, Male | |
| Humans | |
| Immunoglobulin G | |
| Liver Cirrhosis | |
| Liver Neoplasms | |
| Male | |
| Prevalence | |
| RNA, Viral | |
| Renal Dialysis | |
| Sex Workers | |
| Sexual and Gender Minorities | |
| Substance Abuse, Intravenous |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 001 | World Health Organization | International | PubMed | |
| 109130/Z/15/Z | Wellcome Trust | United Kingdom | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06539052 | MIGrant Reflex Test HDV (MIGRED) Project | Results |
Source ClinicalTrials.gov
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 32684365 | The burden of hepatitis D - defogging the epidemiological horizon. | https://conductscience.org/library/papers/32684365 | PubMed |
| Comment in | 32829929 | Revisiting the estimation of hepatitis D global prevalence. | https://conductscience.org/library/papers/32829929 | PubMed |
| Comment in | 32863046 | Reply to: "Revisiting the estimation of hepatitis D global prevalence". | https://conductscience.org/library/papers/32863046 | PubMed |
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25962883 | Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes. | J Hepatol | 2015 | https://conductscience.org/library/papers/25962883 | PubMed |
| 2 | 21511329 | Hepatitis delta virus. | Lancet | 2011 | https://conductscience.org/library/papers/21511329 | PubMed |
| 3 | 29599078 | Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. | Lancet Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/29599078 | PubMed |
| 4 | 27530084 | First international external quality assessment for hepatitis delta virus RNA quantification in plasma. | Hepatology | 2016 | https://conductscience.org/library/papers/27530084 | PubMed |
| 5 | 4825599 | Proportion of disease caused or prevented by a given exposure, trait or intervention. | Am J Epidemiol | 1974 | https://conductscience.org/library/papers/4825599 | PubMed |
| 6 | 30368454 | Devil hepatitis D: an orphan disease or largely underdiagnosed? | Gut | 2019 | https://conductscience.org/library/papers/30368454 | PubMed |
| 7 | 26317388 | Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. | Int J Evid Based Healthc | 2015 | https://conductscience.org/library/papers/26317388 | PubMed |
| 8 | 11782040 | A refined method for the meta-analysis of controlled clinical trials with binary outcome. | Stat Med | 2001 | https://conductscience.org/library/papers/11782040 | PubMed |
| 9 | 30771261 | New treatment options for delta virus: Is a cure in sight? | J Viral Hepat | 2019 | https://conductscience.org/library/papers/30771261 | PubMed |
| 10 | 25242656 | Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. | BMC Med | 2014 | https://conductscience.org/library/papers/25242656 | PubMed |
| 11 | 28964701 | Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial. | Lancet Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/28964701 | PubMed |
| 12 | 28983565 | The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/28983565 | PubMed |
| 13 | 26231459 | Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. | Lancet | 2015 | https://conductscience.org/library/papers/26231459 | PubMed |
| 14 | 27880976 | A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians. | Hepatology | 2017 | https://conductscience.org/library/papers/27880976 | PubMed |
| 15 | 30567743 | Hepatitis D prevalence: problems with extrapolation to global population estimates. | Gut | 2020 | https://conductscience.org/library/papers/30567743 | PubMed |
| 16 | 11406840 | On tests of the overall treatment effect in meta-analysis with normally distributed responses. | Stat Med | 2001 | https://conductscience.org/library/papers/11406840 | PubMed |
| 17 | 10673308 | Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). | Gut | 2000 | https://conductscience.org/library/papers/10673308 | PubMed |
| 18 | 29888837 | Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy. | J Viral Hepat | 2018 | https://conductscience.org/library/papers/29888837 | PubMed |
| 19 | 30342879 | Pathogenesis of and New Therapies for Hepatitis D. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30342879 | PubMed |
| 20 | 24523467 | Serological and molecular diagnosis of hepatitis delta virus infection: results of a French national quality control study. | J Clin Microbiol | 2014 | https://conductscience.org/library/papers/24523467 | PubMed |
Cited by343
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 565 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42944025 | Frequency of CAP-Defined Hepatic Steatosis and Its Association with Liver Fibrosis in Patients with Hepatitis Delta. | Viruses | 2026 | https://conductscience.org/library/papers/42944025 | PubMed |
| 42931375 | Assessing the Status of and Impediments to Achieving the WHO Goal to Eliminate Viral Hepatitis B by 2030: A Scoping Review. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42931375 | PubMed |
| 42891145 | Spontaneous Bilateral Vesical Artery Pseudoaneurysms Presenting With Massive Recurrent Hematuria and Obstructive Acute Kidney Injury: A Case Report. | Clin Case Rep | 2026 | https://conductscience.org/library/papers/42891145 | PubMed |
| 42875707 | The Economic Burden of HDV in Italy: Evaluating the Potential Impact and Effects of Bulevirtide for Chronic HDV Infection. | Clin Drug Investig | 2026 | https://conductscience.org/library/papers/42875707 | PubMed |
| 42869501 | Cas d’un homme ayant reçu un diagnostic d’hépatite B à l’âge de 40 ans. | CMAJ | 2026 | https://conductscience.org/library/papers/42869501 | PubMed |
| 42866439 | Tobevibart plus elebsiran for the treatment of hepatitis D: how should we read the phase 2 data? | Transl Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42866439 | PubMed |
| 42828159 | Therapeutic, preventive, and pathogenetic advances in viral hepatitis. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42828159 | PubMed |
| 42797761 | Emergency Department-Based Screening and Linkage-to-Care for Hepatitis B, C, and D in a Referral Hospital in Barcelona, Spain: Reduction in Hepatitis C Prevalence After Five Years. | Viruses | 2026 | https://conductscience.org/library/papers/42797761 | PubMed |
| 42769913 | Promoting expertise knowledge sharing in paediatric virology: An update (Review). | Exp Ther Med | 2026 | https://conductscience.org/library/papers/42769913 | PubMed |
| 42761485 | Development and External Validation of an Algorithm for Identifying HDV RNA-Positive Patients. | Gastro Hep Adv | 2026 | https://conductscience.org/library/papers/42761485 | PubMed |
| 42740976 | Health Disparities in Hepatitis D Virus Management: A Case Series on Improving Patient Access to Bulevirtide Therapy. | Gastro Hep Adv | 2026 | https://conductscience.org/library/papers/42740976 | PubMed |
| 42724814 | Recommendations for treatment of viral hepatitis B in 2026 by the Polish Group of Experts for HBV. | Clin Exp Hepatol | 2026 | https://conductscience.org/library/papers/42724814 | PubMed |
| 42715288 | Mathematical modeling of HBV-HDV transmission with superinfection: The role of vaccination and liver transplantation in disease dynamics. | PLoS One | 2026 | https://conductscience.org/library/papers/42715288 | PubMed |
| 42707868 | CRISPR-based point-of-care diagnostics for viral hepatitis: from molecular design to clinical implementation. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42707868 | PubMed |
| 42655679 | Integrated Diagnosis of Hepatitis B, C, and D Viruses and HIV in Populations Evaluated for Sexually Transmitted Infections: A Narrative Review and Operational Framework. | Viruses | 2026 | https://conductscience.org/library/papers/42655679 | PubMed |
| 42655132 | An Exploratory Evaluation of the Present Prevalence of Hepatitis D Infection in Selected Populations from Venezuela, Contrasted with Past Studies in the Country. | Microorganisms | 2026 | https://conductscience.org/library/papers/42655132 | PubMed |
| 42623246 | Peripheral Biomarkers in Chronic Hepatitis D Infection: A Review. | J Viral Hepat | 2026 | https://conductscience.org/library/papers/42623246 | PubMed |
| 42608708 | Hepatitis B and D burden in Uzbekistan: comprehensive analysis of seroprevalence and risk correlates from a countrywide study. | Infect Dis Poverty | 2026 | https://conductscience.org/library/papers/42608708 | PubMed |
| 42608674 | Seroprevalence of hepatitis D among hepatitis B-infected patients attending the viral hepatitis treatment unit in Alexandria, Egypt: a prospective cross-sectional observational study. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/42608674 | PubMed |
| 42605247 | Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta-Analysis. | J Viral Hepat | 2026 | https://conductscience.org/library/papers/42605247 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32335166
GET https://conductscience.org/api/papers/v1/32335166/references?page=2